Release of Apoptogenic Proteins from Brain Mitochondria
Release of Apoptogenic Proteins from Brain Mitochondria
批准号:
7547738
负责人:
Nickolay Brustovetsky
金额:
$25.9万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-12-01 至 2011-11-30
关键词:
ATP sensitive potassium channel complexAdenine Nucleotide TranslocaseAntioxidantsApoptosisApoptoticBAX geneBrainBrain EdemaCaspaseCell DeathCellsCessation of lifeDNADiagnosticFoundationsGenerationsGoalsInner mitochondrial membraneKnowledgeLaboratoriesLeadLipid PeroxidationLiposomesMembraneMitochondriaMitochondrial ProteinsMolecularNerve DegenerationNeuronsOrganellesOuter Mitochondrial MembranePermeabilityPhospholipase A2Phospholipases APhospholipidsPositioning AttributePotassium ChannelProcessProtein FamilyProteinsReactive Oxygen SpeciesRecombinantsResearchResearch PersonnelRoleRuptureStrokeSwellingTestingTherapeuticWorkapoptosis inducing factorcytochrome cdesignendonuclease Gexperienceinhibitor/antagonistmembermitochondrial K(ATP) channelnervous system disorderneuron apoptosisneuropathologynovelphospholipase A2 inhibitorpro-apoptotic proteinprogramstool
中文摘要
描述(由申请人提供):我们对Ca2+升高和促凋亡蛋白诱导的线粒体凋亡因子释放机制的理解存在根本差距。我们的长期目标是确定线粒体在神经元凋亡中的作用。本研究的目的是描述脑线粒体释放凋亡蛋白的机制,由升高的Ca2+或促凋亡蛋白启动。该研究的中心假设是活性氧的增加、脂质过氧化的增强、磷脂酶A2的激活和脑线粒体中的K+内流是导致Ca2+或促凋亡蛋白tBID和BAX升高诱导的凋亡蛋白释放的主要过程。在Specific Aim 1中,我们将建立Ca2+诱导脑线粒体肿胀和凋亡蛋白释放的K+依赖机制。线粒体K+通道和腺嘌呤核苷酸转位酶抑制剂将应用于分离的脑线粒体或培养的神经元,以确定它们在Ca2+诱导的肿胀和凋亡蛋白释放中的作用。在Specific Aim 2中,我们将确定线粒体K+通道的激活和通透性转变对促凋亡蛋白tBID和BAX诱导的凋亡因子释放的贡献程度。将使用渗透性过渡抑制剂和K+通道阻滞剂来确定它们在凋亡蛋白释放中的作用。在Specific Aim 3中,我们将建立活性氧、脂质过氧化和磷脂酶A2在tBID和BAX诱导的凋亡蛋白释放中的作用。各种抗氧化剂和磷脂酶A2抑制剂将被用来抑制凋亡蛋白的释放。在特异性目的4中,我们将确定半胱天冬酶在暴露于tBID和BAX的脑线粒体释放凋亡蛋白中的作用。分离的脑线粒体暴露于tBID和BAX,并用重组半胱天冬酶处理,将用于验证这一假设。本研究为更好地理解ca2 +升高或促凋亡蛋白tBID和BAX诱导线粒体外膜通透性的分子机制奠定了基础,并有助于填补我们对这些现象的认识空白。
英文摘要
DESCRIPTION (provided by applicant): There is a fundamental gap in our understanding of the mechanisms of the release of mitochondrial apoptogenic factors induced by elevated Ca2+ and by pro-apoptotic proteins. Our long-term goal is to establish the role of mitochondria in neuronal apoptosis. The objective of this study is to delineate the mechanisms of release of apoptogenic proteins from brain mitochondria initiated by elevated Ca2+ or by pro-apoptotic proteins. The central hypothesis of the proposed research is that an increased generation of reactive oxygen species, augmentation of lipid peroxidation, activation of phospholipase A2, and K+ influx in brain mitochondria are the major processes leading to the release of apoptogenic proteins induced by elevated Ca2+ or pro-apoptotic proteins tBID and BAX. In Specific Aim 1 we will establish K+-dependent mechanisms of the Ca2+-induced swelling of brain mitochondria and release of apoptogenic proteins. Inhibitors of mitochondrial K+ channels and the adenine nucleotide translocase will be applied to isolated brain mitochondria or to cultured neurons to establish their role in the Ca2+-induced swelling, and release of apoptogenic proteins. In Specific Aim 2 we will determine the extent to which an activation of mitochondrial K+ channels and the permeability transition contributes to the release of apoptogenic factors induced by pro-apoptotic proteins tBID and BAX. Inhibitors of the permeability transition and blockers of K+ channels will be used to identify their role in the release of the apoptogenic proteins. In Specific Aim 3 we will establish the role of reactive oxygen species, lipid peroxidation and phospholipase A2 in the release of apoptogenic proteins induced by tBID and BAX. Various antioxidants and inhibitors of phospholipase A2 will be used to inhibit the release of apoptogenic proteins. In Specific Aim 4 we will determine the role of caspases in the release of apoptogenic proteins from brain mitochondria exposed to tBID and BAX. Isolated brain mitochondria exposed to tBID and BAX and treated with recombinant caspases will be used to test this hypothesis. The proposed research lays the foundation for a better understanding of the molecular mechanisms of the permeabilization of the outer mitochondrial membrane induced by elevated Ca 2+ or pro-apoptotic proteins tBID and BAX and contributes to filling in a gap in our knowledge of these phenomena.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.nbd.2011.12.051
发表时间:
2012-04
期刊:
NEUROBIOLOGY OF DISEASE
影响因子:
6.1
作者:
[Brittain, Matthew K., Brustovetsky, Tatiana, Sheets, Patrick L., Brittain, Joel M., Khanna, Rajesh, Cummins, Theodore R., Brustovetsky, Nickolay]
通讯作者:
Brustovetsky, Nickolay
DOI:
10.1002/jnr.22295
发表时间:
2010-05-01
期刊:
JOURNAL OF NEUROSCIENCE RESEARCH
影响因子:
4.2
作者:
[Brustovetsky, Tatiana, Bolshakov, Alexey, Brustovetsky, Nickolay]
通讯作者:
Brustovetsky, Nickolay
DOI:
10.1016/j.bbabio.2008.08.002
发表时间:
2008-11
期刊:
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
影响因子:
4.3
作者:
[Li, Tsyregma, Brustovetsky, Tatiana, Antonsson, Bruno, Brustovetsky, Nickolay]
通讯作者:
Brustovetsky, Nickolay
Neuroprotective effect of KB-R7943 against glutamate excitotoxicity is related to mild mitochondrial depolarization.
KB-R7943 针对谷氨酸兴奋毒性的神经保护作用与轻度线粒体去极化有关。
DOI:
10.1007/s11064-009-0058-x
发表时间:
2010
期刊:
Neurochemical research
影响因子:
4.4
作者:
[Storozhevykh,TP, Senilova,YaE, Brustovetsky,T, Pinelis,VG, Brustovetsky,N]
通讯作者:
Brustovetsky,N
DOI:
10.1016/j.neuropharm.2012.07.012
发表时间:
2012-11
期刊:
Neuropharmacology
影响因子:
4.7
作者:
[Brittain MK, Brustovetsky T, Brittain JM, Khanna R, Cummins TR, Brustovetsky N]
通讯作者:
Brustovetsky N
共 6 条
CRMP2, mitochondria, and Huntington’s disease
-
批准号:9316237
-
项目类别:
-
资助金额:$57.45万
-
财政年份:2017
-
负责人:Nickolay Brustovetsky
-
依托单位:
CRMP2, mitochondria, and Huntington’s disease
-
批准号:9884828
-
项目类别:
-
资助金额:$56.1万
-
财政年份:2017
-
负责人:Nickolay Brustovetsky
-
依托单位:
Mitochondrial Porin in Bioenergetic Defects in Huntingtons Disease
-
批准号:8616413
-
项目类别:
-
资助金额:$33.52万
-
财政年份:2012
-
负责人:Nickolay Brustovetsky
-
依托单位:
Mitochondrial Porin in Bioenergetic Defects in Huntingtons Disease
-
批准号:8416946
-
项目类别:
-
资助金额:$32.68万
-
财政年份:2012
-
负责人:Nickolay Brustovetsky
-
依托单位:
Mitochondrial Porin in Bioenergetic Defects in Huntingtons Disease
-
批准号:8271933
-
项目类别:
-
资助金额:$33.79万
-
财政年份:2012
-
负责人:Nickolay Brustovetsky
-
依托单位:
Release of Apoptogenic Proteins from Brain Mitochondria
-
批准号:6987901
-
项目类别:
-
资助金额:$26.72万
-
财政年份:2004
-
负责人:Nickolay Brustovetsky
-
依托单位:
Release of Apoptogenic Proteins from Brain Mitochondria
-
批准号:7152942
-
项目类别:
-
资助金额:$25.94万
-
财政年份:2004
-
负责人:Nickolay Brustovetsky
-
依托单位:
Release of Apoptogenic Proteins from Brain Mitochondria
-
批准号:7340745
-
项目类别:
-
资助金额:$25.94万
-
财政年份:2004
-
负责人:Nickolay Brustovetsky
-
依托单位:
Release of Apoptogenic Proteins from Brain Mitochondria
-
批准号:6850275
-
项目类别:
-
资助金额:$27.36万
-
财政年份:2004
-
负责人:Nickolay Brustovetsky
-
依托单位:
海外基金